What I would like to know is what is really stopping the SP from sliding almost into oblivion?There have been many on this post that have tried to put a positive spin on this, but I am not to optimistic.
PRR has cash ~ 28 million plus IP NO DEBT
PHASE ii b inconclusive re: PFS endpoint
Now looking at OS and if dendron can get provenge up with 4.1 months overall survival over SOC with dubious alleged statistical analysis then CVac still got a shot.
New end primary end point of Overall survival in all future trials will in the long term pay off but risk/reward didn't pay off after years of hope and CRs this time.
My passion is I hate cancer and immunology is great way to fight the scurge.
IMO immuology like CVac combined with other treatments will be the future.
A partner would be good now for the SP with this spec stock imo.
Cheers
cvac not toxic but others are so!, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |